Adjuvant Systemic Immunotherapies for Resected Stage III Melanoma: A Single-Centre Retrospective Clinical Practice Review
2025 · International Journal of Molecular Sciences · 3 citations
https://doi.org/10.3390/ijms26020750
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
65
Citations
4
h-index
2
i10-index
Panagiotis Koliou is an academic researcher from Royal Surrey County Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & HER2/EGFR in Cancer Research & Mathematical Biology Tumor Growth. The author has an h-index of 4, co-authored 15 publications.
https://doi.org/10.3390/ijms26020750
https://doi.org/10.3390/ijms25052616
https://doi.org/10.24911/ejmcr/173-1602946910
Click to start Chat